FDA approves first dermal filler to treat acne scarring

By Natalie Grover (Reuters) – The U.S. Food and Drug Administration approved the first dermal filler to treat scarring caused by acne, the most common skin disorder in the United States afflicting 40-50 million people. Bellafill, developed by privately held Suneva Medical Inc, is made primarily of bovine collagen. When injected, it lifts and smoothens pitted scars to the level of the surrounding skin. It is designed to treat moderate to severe acne scars on the cheeks of patients over the age of 21, Suneva said on Tuesday. A cure for acne has long eluded drug developers. …
Go to Source